Global Molecular Diagnostics Market 2024-2030
  • CHOOSE LICENCE TYPE
Consulting Services
    How will you benefit from our consulting services ?

Global Molecular Diagnostics Market 2024-2030

Last Updated:  Apr 25, 2025 | Study Period: 2024-2030

MOLECULAR DIAGNOSTICS MARKET

 

INTRODUCTION TOMOLECULAR DIAGNOSTICS MARKET

 

The study of biological markers at the molecular level, especially DNA, RNA, and proteins, is the focus of the rapidly developing discipline of molecular diagnostics in biology and medicine. This method enables more precise diagnosis, prognosis, and therapy choices by offering insightful information on the genetic and molecular pathways underlying numerous diseases and ailments.

 

Precision is one of the most important features of molecular diagnostics. Healthcare practitioners can determine the presence of pathogens like viruses or bacteria, as well as mutations or genetic variants linked to inherited illnesses or cancer, by looking at the genetic material or specific proteins in a patient's sample, such as blood, tissue, or bodily fluids.

 

With such accuracy, sickness can be identified early and treated with individualized plans that take into account each person's particular genetic profile.

 

Infectious disease management, cancer screening, and treatment response monitoring all rely heavily on molecular diagnostics. These analyses are frequently performed using methods like polymerase chain reaction (PCR), next-generation sequencing (NGS), and immunoassays.

 

These tests yield information that is useful for diagnosis as well as for ongoing research and the creation of novel therapy strategies, ushering in a new era of medicine that is more data-driven and individualized. The medical and scientific communities' efforts to enhance patient well-being and healthcare outcomes are led by molecular diagnostics.

 

MOLECULAR DIAGNOSTICS MARKETSIZE AND FORECAST

infographic: Molecular Diagnostics Market, Molecular Diagnostics Market Size, Molecular Diagnostics Market Trends, Molecular Diagnostics Market Forecast, Molecular Diagnostics Market Risks, Molecular Diagnostics Market Report, Molecular Diagnostics Market Share

 

The Global Molecular Diagnostics Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

 

MOLECULAR DIAGNOSTICS MARKETRECENT DEVELOPMENT

 

The Cobas 5800 System, a portable, fully automated molecular laboratory tool that provides a versatile PCR testing option to help doctors diagnose infectious diseases, will go on sale in the United States, according to plans released by Roche. The Cobas 5800 is built on the tried-and-true technological foundation of the Cobas 6800/8800 Systems and is intended to offer labs of all sizes improved workflow efficiencies, simplicity, and quick results.

 

The Cobas HIV-1 assay, the first of the Cobas x800 family of assays available for use on the Cobas 5800 System, a Class 2 exempt medical device, has been given premarket approval by the U.S. Food and Drug Administration. 

 

Real-time molecular testing is made possible by the Cobas 5800 System, which has a small footprint and great performance. The Cobas 5800 System is a scalable, economical solution for smaller labs wanting big lab performance, or for larger labs seeking small lab agility. It offers automation, consolidation, integration, and standardization. 

 

The system is designed to provide an entirely automated workflow that includes sample transfer and preparation, amplifying and detecting, computing results, and delivering them to the lab information system.

 

THIS MOLECULAR DIAGNOSTICS MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

 

  1. How many Molecular Diagnostics are manufactured per annum globally? Who are the sub-component suppliers in different regions?
  2. Cost breakup of Global Molecular Diagnostics and key vendor selection criteria
  3. Where is the Molecular Diagnostics manufactured? What is the average margin per unit?
  4. Market share of Global Molecular Diagnostics market manufacturers and their upcoming products
  5. Cost advantage for OEMs who manufacture Global Molecular Diagnostics in-house
  6. key predictions for the next 5 years in the Global Molecular Diagnostics market
  7. Average B-2-B Molecular Diagnostics market price in all segments
  8. Latest trends in the Molecular Diagnostics market, by every market segment
  9. The market size (both volume and value) of the Molecular Diagnostics market in 2024-2030 and every year in between?
  10. Production breakup of the Molecular Diagnostics market, by suppliers and their OEM relationship

 

Sl noTopic
1Market Segmentation
2Scope of the report
3Abbreviations
4Research Methodology
5Executive Summary
6Introduction
7Insights from Industry stakeholders
8Cost breakdown of Product by sub-components and average profit margin
9Disruptive innovation in the Industry
10Technology trends in the Industry
11Consumer trends in the industry
12Recent Production Milestones
13Component Manufacturing in US, EU and China
14COVID-19 impact on overall market
15COVID-19 impact on Production of components
16COVID-19 impact on Point of sale
17Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
18Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
19Market Segmentation, Dynamics and Forecast by Application, 2024-2030
20Market Segmentation, Dynamics and Forecast by End use, 2024-2030
21Product installation rate by OEM, 2023
22Incline/Decline in Average B-2-B selling price in past 5 years
23Competition from substitute products
24Gross margin and average profitability of suppliers
25New product development in past 12 months
26M&A in past 12 months
27Growth strategy of leading players
28Market share of vendors, 2023
29Company Profiles
30Unmet needs and opportunity for new suppliers
31Conclusion
32Appendix